Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-5-26
pubmed:abstractText
Immunocytochemistry (ICC) of thyroid peroxidase (TPO) using the monoclonal antibody MoAb47 has been used as malignancy marker on thyroid fine needle aspiration. However, little is known about the fate of TPO in thyroid carcinoma. We performed a qualitative PCR (Q-PCR) analysis to measure the expression of variants of tpo mRNA in 13 normal tissue samples, 30 benign tumors (BT), 21 follicular carcinomas (FC), 20 classical papillary carcinomas (PCc), 12 follicular variants of papillary carcinomas (PCfv) and nine oncocytic carcinomas (OC). We also studied mutations involving the ras, Braf, ret or pax8 genes. Results of Q-PCR were closely correlated with those of ICC (P < 0.0001; R = 0.59) and showed that overall tpo expression was lower in all carcinomas than in normal and BT (P < 0.05). The ratio tpo2 or tpo3 to tpo1 was inversed in follicular tumors. Genetic mutations were observed in 90% of PCc, 61.9% of FC, 41.7% of PCfv, 0% of OC and 10% in BT. pax8-ppar gamma1 rearrangement was correlated with qualitative changes in tpo mRNA (P < 0.01). These results confirmed the decrease of TPO expression in 97% of thyroid carcinomas regardless of histological type and the overexpression of shorter splice variants in follicular tumors. Both reduction in quantity of TPO and impairment of its maturation process could account for the atypical immunohistochemical reaction of MoAb47 with TPO.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1351-0088
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
485-95
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16728576-Adult, pubmed-meshheading:16728576-Aged, pubmed-meshheading:16728576-Carcinoma, pubmed-meshheading:16728576-Down-Regulation, pubmed-meshheading:16728576-Female, pubmed-meshheading:16728576-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16728576-Genes, Neoplasm, pubmed-meshheading:16728576-Genes, ras, pubmed-meshheading:16728576-Humans, pubmed-meshheading:16728576-Iodide Peroxidase, pubmed-meshheading:16728576-Male, pubmed-meshheading:16728576-Middle Aged, pubmed-meshheading:16728576-Mutation, pubmed-meshheading:16728576-Paired Box Transcription Factors, pubmed-meshheading:16728576-Proto-Oncogene Proteins B-raf, pubmed-meshheading:16728576-Proto-Oncogene Proteins c-ret, pubmed-meshheading:16728576-RNA, Messenger, pubmed-meshheading:16728576-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16728576-Thyroid Neoplasms
pubmed:year
2006
pubmed:articleTitle
Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf , ras and pax8 genes.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale (U555), IPHM, Faculty of Medicine, Mediterranean University, 27 Bd Jean Moulin, 13385 Marseilles cedex 5, 13385 France. judicristofaro@hotmail.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't